Simplex Trading’s Lantern Pharma LTRN Stock Holding History

Simplex Trading’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-600	Closed	-$822	–	9882
2026 Q1	$822	Sell	600 -1,000	-63%	-$2.8K	﹤0.01%	8641
2025 Q4	$4.85K	Hold	1,600	–	–	﹤0.01%	7449
2025 Q3	$6K	Sell	1,600 -2,900	-64%	-$12.1K	﹤0.01%	8202
2025 Q2	$14K	Sell	4,500 -10,100	-69%	-$34.1K	﹤0.01%	7065
2025 Q1	$51K	Buy	+14,600	New	+$60.6K	﹤0.01%	5754
2024 Q4	–	Sell	-6,700	Closed	-$24K	–	9150
2024 Q3	$24K	Sell	6,700 -600	-8%	-$2.47K	﹤0.01%	6532
2024 Q2	$34K	Sell	7,300 -3,800	-34%	-$22.9K	﹤0.01%	6452
2024 Q1	$97K	Buy	11,100 +8,900	+405%	+$47.6K	﹤0.01%	5612
2023 Q4	$9K	Buy	+2,200	New	+$7.76K	﹤0.01%	7515
2023 Q2	–	Sell	-4,700	Closed	-$22K	–	9524
2023 Q1	$22K	Buy	+4,700	New	+$24.7K	﹤0.01%	6818
2022 Q1	–	Sell	-200	Closed	-$1K	–	10983
2021 Q4	$1K	Buy	+200	New	+$1.83K	﹤0.01%	10204

Other funds holding LTRN

EAM

Empery Asset Management New York $86.5M AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Simplex Trading's LTRN Position: Q2 2026 in Review

Simplex Trading increased its Lantern Pharma (LTRN) stake by 2,084% in Q2 2026, buying an estimated $6.54K and bringing the position to 2,337 shares worth $9.74K. The position accounts for ﹤0.01% of the portfolio, ranked #7710.

Simplex Trading first reported a position in LTRN in Q1 2022 and has held it in 10 quarters since. The position peaked at $25K in Q1 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

Simplex Trading held 2,337 shares of Lantern Pharma worth $9.74K as of Q2 2026.
Simplex Trading bought 2,230 Lantern Pharma shares in Q2 2026, an estimated $6.54K.
Lantern Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7710 holding.
Simplex Trading first reported a position in Lantern Pharma in Q1 2022 and has held it in 10 quarters since.
Simplex Trading's Lantern Pharma position peaked at $25K in Q1 2024.
39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.